#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myeloid leukaemia (in remission) Lung adenocarcinoma Arteriovenous malformation Congenital growth hormone deficiency Richter's syndrome Diffuse large B-cell lymphoma Glycogen storage disease type V Chronic lymphocytic leukaemia refractory Fungal infection Red blood cell abnormality Bronchiolitis Choroidal dystrophy Partial lipodystrophy Neuroendocrine tumour of the lung Medullary thyroid cancer More trials…

    Learn about Rare Diseases

    Chordoma – Diagnostics Gaucher’s disease type I – Diagnostics Short-bowel syndrome – Treatment Pulmonary sarcoidosis – Basic Information Langerhans’ cell histiocytosis – Treatment Antisynthetase syndrome – Treatment Glomerulonephritis membranous – Diagnostics Mantle cell lymphoma stage II – Trials in Disease Splenic marginal zone lymphoma – Life with Disease CADASIL – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lenacapavir ACARBOSE Water For Injection Calcium Diroximel Fumarate Tyrosine SELTOREXANT Metformin Ag-946 Gentamicin Sulfate Nadroparin Calcium Mepacrine Ribonucleic Acid K10 OMECAMTIV MECARBIL Valemetostat Tosilate Levetiracetam Protein S Dactinomycin Pyrimethamine Paclitaxel Obaluronate More therapies…

    Learn about Your Condition

    Juvenile spondyloarthritis Hypotension Laryngeal cancer Tuberous sclerosis complex Testicular germ cell tumour Spinal muscular atrophy Hypoxia Mantle cell lymphoma Thrombosis Retinopathy proliferative Postpartum haemorrhage Neck pain Heparin resistance IgA nephropathy Diabetes insipidus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Conjunctivitis allergic

  • Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

    Recruiting

    3 1
    Investigated Drugs:
    • Dactylis Glomerata Pollen Extract
    • Festuca Elatior Pollen Extract
    • Lolium Perenne Pollen Extract
    Portugal Spain

  • Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis
    • Conjunctivitis allergic
    Investigated Drugs:
    • Dactylis Glomerata Pollen Extract
    • Festuca Elatior Pollen Extract
    • Lolium Perenne Pollen Extract
    Portugal Spain

  • Study of bilastine for effectiveness, safety and quality of life in children aged 6 to 12 years with allergic rhinoconjunctivitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Bilastine
    Italy Poland Spain

  • Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Mite allergy
    • Rhinitis allergic
    Portugal Spain

  • Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

    Recruiting

    3 1
    Portugal Spain

  • Study on the Effectiveness and Safety of Sublingual MM09 for Patients Aged 12-65 with Allergies to House Dust Mites and Rhinitis/Rhinoconjunctivitis with or without Asthma

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Mite allergy
    • Rhinitis allergic
    Investigated Drugs:
    • Dermatophagoides Farinae Extract
    • Dermatophagoides Pteronyssinus Extract
    Portugal Spain
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!